CoChat

C1q receptors

Open access
Eggleton, P, Tenner, A J, Reid, K B M · 2001 · Clinical and Experimental Immunology
Cited by 86

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The complement system consists of over 20 plasma proteins, which are activated and regulated by enzymes of the serine protease type. There are three recognized routes leading to activation of the complement system, the classical, and the alternative and mannan-binding lectin (MBL) pathways. Upon activation, some of the complement proteins are cleaved into small fragments that can be recognized and bound by complement receptors on the surfaces of various cell types. A primary function of the complement cell surface receptors is to enhance the responsiveness of the innate immune system in destroying and removing proteins, microorganisms and other foreign material as well as cellular debris from the circulation. A number of complement receptors have been found on specialized cell types and characterized at the molecular and biochemical level, including complement receptor 1 (CR1, CD35), complement receptor 2 (CR2, CD21), complement receptor 3 (CR3, CD11b/CD18) complement receptor 4 (CR4, CD11c/CD18) and the C5a receptor (CD88). In 1977, Sobel and co-workers observed saturable and concentration-dependent binding of C1q to B lymphocytes and other cells of a lymphoblastoid lineage [1]. Since then, a number of researchers have observed that C1q, a subcomponent of the first component of complement, is also capable of modulating diverse cellular responses, and this has resulted in an intense search for C1q binding proteins which may be C1q receptors. A number of intracellular and cell surface proteins which interact with C1q and may or may not be receptors for C1q have been found (Table 1). Proteins that have been proposed as receptors for the first component of complement, C1q Proteins that have been proposed as receptors for the first component of complement, C1q The most characterized immunological function of C1q is as the recognition component for the activation of the classical complement pathway. However, it is known that C1q is synthesized and secreted in the absence of C1r and C1s, the other components of C1, the classical complement pathway initiation complex. In addition, C1q is found in vivo in the absence of C1r and C1s, and thus additional roles for C1q are plausible. The proteins discussed in this review that have been proposed to be C1q receptors involved in these alternative roles are diverse, consisting of novel cell surface proteins present on specific cells, ubiquitous intracellular proteins, or known receptors for complement components other than C1q. There is still much work required before immunologists can be confident that specific C1q receptors are responsible for triggering or modulating host responses or for initiating specific signal transduction mechanisms within the cell. Nevertheless, this review describes the evidence so far that implicates a role for each of these C1q binding proteins either as genuine receptors or as modulators of pathological and physiological processes in which C1q is involved. The C1 complex of the classical pathway comprises three glycoproteins, C1q, C1r and C1s. The trigger for complement activation occurs in vivo by the interaction of the C1q portion of the C1 complex with immune complexes (IC) or other known non-immunoglobulin C1 activators [2,3] The C1q molecule is a 460 000-D glycoprotein composed of six globular ‘heads’, each of which are 5 nm across and 7 nm in depth and held together by six collagen-like ‘stalks’. Each head is composed of the C-terminal halves of three distinct polypeptide A, B and C chains, and these heads are connected to collagen-like strands which extend 11 nm and link to a central elongated triple helical fibril structure of 11·2 nm in length also composed of a collagen-like repeating sequence of Gly-X-Y triplets. Dimers of the C1r and C1s subcomponents contain the enzymatic activities associated with the C1 complex and form a tetrameric proenzyme structure around the collagen-like stands of C1q. The heads of C1q function in molecular recognition of defined regions within the CH2 domain of antigen-complexed IgG molecules. Recent studies employing portions of recombinant C1q heads have indicated that the C1qB chain is important in IgG binding [4], while chemical modification studies imply all three chains may be involved for optimum binding. The recent crystal structure of the globular head of adipocyte complement-related protein of 30 kD (ACRP30), a C1q-like protein, reveals that it is analogous to regions of the tumour necrosis factor family (TNF) that are directly involved in interaction with their receptors [5]. The head region of C1q is clearly involved in specific protein–protein interactions, but less definitive information has been reported concerning possible functions for the collagen-like tail region of C1q. After activation of the C1 complex by immune aggregates the activated C1r2-C1s2 enzymes are rapidly removed from the collagen-like region of C1q by covalent interaction with the serum C1-inhibitor. This, as well as pr

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2249.2000.01218.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 86

Metadata

Authors
Eggleton, P., Tenner, A. J., & Reid, K. B. M.
Venue
Clinical and Experimental Immunology
Published
2000-06
Volume
120
Issue
3
Pages
406-412
ISSN
  • 0009-9104 (ISSN-L)
  • 1365-2249
OpenAlex
W4249474474
Cited by
86
References
2
FWCI
1.35
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: C1q receptors. https://app.cochat.ai/papers/10.1046/j.1365-2249.2000.01218.x
The paper
Eggleton, P., Tenner, A. J., & Reid, K. B. M. (2001). C1q receptors. Clinical and Experimental Immunology. https://doi.org/10.1046/j.1365-2249.2000.01218.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.